ViroCell's virtual workshop at Phacilitate, August 2023

Vector design and optimization are critical to ensuring your candidate is stable, manufacturable, and ready to progress to clinical studies.

Delays often occur when a vector product has to be remade and it lands at the back of the manufacturing queue.  

Do you want to de-risk your critical vector and accelerate your pathway to the clinic?

Phacilitate & Team ViroCell are hosting ‘A Design Team’s Views on Optimizing your Viral Vector for Clinical Success’, a virtual interactive workshop to discuss strategies and learnings from their experience of manufacturing ~200 viral vectors for clinical trials.

On August 24th, Join CEO John W. Hadden II; Chief Scientific Officer Farzin Farzaneh, PhD; Director, Process Development & Innovation Carlo Scala, and Principal Scientist, Innovation Glenda J Dickson PhD.

For information on how to watch the video of the workshop, please email info@virocell.com